Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 14/20 | 0.46 |
| ▸ | PPARG | P37231 | 5/20 | 0.43 |
| ▸ | PPARD | Q03181 | 5/20 | 0.43 |
| ▸ | PPARA | Q07869 | 5/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | HTR1D | P28221 | 1/20 | 0.37 |
| ▸ | HTR1B | P28222 | 1/20 | 0.37 |
| ▸ | HTR1E | P28566 | 1/20 | 0.37 |
| ▸ | HTR1F | P30939 | 1/20 | 0.37 |
| ▸ | HTR7 | P34969 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5350312 | 0.92 | PPARG (0.53) | HTR6PPARGPPARDPPARAHTR1A | |
| SCHEMBL5355636 | 0.92 | PPARG (0.53) | HTR6PPARGPPARDPPARAHTR1A | |
| SCHEMBL5371295 | 0.92 | PPARG (0.53) | HTR6PPARGPPARDPPARAHTR1A | |
| SCHEMBL5355852 | 0.92 | PPARG (0.53) | HTR6PPARGPPARDPPARAHTR1A | |
| SCHEMBL5359036 | 0.85 | HTR6 (0.61) | HTR6PPARGPPARDPPARAHTR1A | |
| SCHEMBL5361336 | 0.81 | HTR6 (0.48) | HTR6PPARGPPARDPPARA | |
| SCHEMBL5362401 | 0.81 | HTR6 (0.48) | HTR6PPARGPPARDPPARA | |
| SCHEMBL5352434 | 0.81 | HTR6 (0.48) | HTR6PPARGPPARDPPARA | |
| SCHEMBL6519761 | 0.81 | HTR6 (0.48) | HTR6PPARGPPARDPPARA | |
| SCHEMBL5355639 | 0.76 | PPARG (0.72) | HTR6PPARGPPARDPPARAHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7307098-B2 | Indole derivatives and drugs containing the same | MEIJI DAIRIES CORPORATION (JP) | 2007-12-11 | — | — | US | disclosed |
| US-20050261357-A1 | Indole derivatives and drugs containing the same | MEIJI DAIRIES CORPORATION (JP) | 2005-11-24 | — | — | US | disclosed |
| EP-1533299-A1 | INDOLE DERIVATIVES AND DRUGS CONTAINING THE SAME | Meiji Dairies Corporation (JP) | 2005-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261357-A1 | Indole derivatives and drugs containing the same | IDO1, TPH1, IDO2 | HTR6 26/4885PPARG 4365/4885PPARD 4437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.